Drug Shortage Report for APO-SERTRALINE

Last updated on 2018-01-31 History
Report ID 28709
Drug Identification Number 02238282
Brand name APO-SERTRALINE
Common or Proper name SERTRALINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SERTRALINE
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL & 250 BTL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-06
Estimated end date 2018-02-28
Actual end date 2018-01-30
Shortage status Resolved
Updated date 2018-01-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-01-31 French Compare
v9 2018-01-31 English Compare
v8 2017-12-14 French Compare
v7 2017-12-14 English Compare
v6 2017-11-27 French Compare
v5 2017-11-27 English Compare
v4 2017-11-13 French Compare
v3 2017-11-13 English Compare
v2 2017-11-09 French Compare
v1 2017-11-09 English Compare

Showing 1 to 10 of 10